Novavax | NVAX - Interest Income


Novavax reported $303K in Interest Income for its fiscal quarter ending in December of 2021.





Interest Income Change Date
Adma Biologics USD 376K 24K Sep/2025
AstraZeneca USD 85M 17M Sep/2025
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
Cassava Sciences USD 1.17M 47K Sep/2025
Geron USD 4.26M 392K Sep/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
MannKind USD 2.63M 796K Sep/2025
Merck USD 96M 27M Sep/2025
Moderna USD 73M 8M Sep/2025
Novavax USD 303K 27K Dec/2021
Pfizer USD 0.62 156M Sep/2025
Sanofi EUR 114M 38M Sep/2025
Sarepta Therapeutics USD 8.38M 1.24M Sep/2025